Liu et al. [24] described that MSC treatment for acute kidney injury was most effective when applied prior to the development of an inflammatory microenvironment, and in their study, urinary NGAL was described as a potent marker to estimate when to infuse MSCs because it correlated well with the inflammatory state of kidneys. Here, LCN2 is linked to acute kidney injury.